Cardiac Implantable Electronic Device-Related Infective Endocarditis Outcomes
Cardiac implantable electronic device-related infective endocarditis is diagnosed in a third of patients with implantable device related infections.
Endocarditis
Drug Abuse-Related Infective Endocarditis Rising at Alarming Rate
Investigators assessed national trends on the incidence and geographical distribution of drug abuse with infective endocarditis and contributing factors for outcome in this patient population.
Bilirubin: A Novel Indicator for Adverse Prognosis in Infective Endocarditis
Investigators sought to determine the relationship between conjugate bilirubin and adverse prognosis in patients with infective endocarditis.
Is a Switch to Oral Antibiotics a Safe Option in Endocarditis?
However, the results of a study titled Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis investigated whether a partial oral regimen may lead to equivalent outcomes.
High Prevalence of Infective Endocarditis in E faecalis Bacteremia
Data published in the Journal of the American College of Cardiology showed a high prevalence of definite infective endocarditis (IE) in patients with Enterococcus faecalis bacteremia (26%), suggesting that echocardiography should be considered in patients with E faecalis infection. A multicenter study using echocardiography was conducted from January 2014 to December 2016 in 344 consecutive…
Infective Endocarditis Prevalence 26% in Patients With E faecalis
The prevalence of infective endocarditis is about 26 percent among patients with Enterococcus faecalis bacteremia.
No Effect of IDU on Postoperative Mortality in Infective Endocarditis
Early postoperative mortality may not differ between infective endocarditis caused by IDU and non- IDU causes.
Restrictive OPAT Criteria for Infective Endocarditis May Need Revision
A less restrictive criteria for the use of OPAT for patients with infective endocarditis than current IDSA guidelines was efficacious and safe.
Adjunctive Cefiderocol Treats XDR P aeruginosa Endocarditis
Cefiderocol, a novel siderophore cephalosporin, may be successful in patients with persistently bacteremic nosocomial native aortic valve endocarditis.
Infective Endocarditis Incidence Increased After 2007 AHA Recommendations
The 2007 AHA recommendation for antibiotic prophylaxis for only patients at high risk for infective endocarditis may result in increased incidence of the infection.
Next post in Antibiotics, Antimicrobial Resistance
